U.S. Congress Approves Bill To Fund Added FDA Foreign Inspections
This article was originally published in PharmAsia News
Executive Summary
The U.S. Congress voted overwhelmingly for compromise legislation that would expand the FDA's ability to conduct inspections in foreign countries such as China and India.